| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.25 | 0.4 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.25 | 0.4 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |